ĐẶC ĐIỂM HỘI CHỨNG CHUYỂN HÓA VÀ MỘT SỐ YẾU TỐ LIÊN QUAN Ở BỆNH NHÂN VIÊM KHỚP CỘT SỐNG

Abstract

Object: Determine the rate of metabolic syndrome in patients with spondyloarthritis and some related factors. Method: Descriptive, cross-sectional study on 71 patients diagnosed with spondyloarthritis from September 2023 to June 2024 in Bach Mai hospital and Ha Noi Medical University Hospital. Result: The rate of metabolic syndrome in patients with spondyloarthritis is 29,6%, in which, hypertension is the most common factor (53,5%). Patients in groups of age ≥ 35, overweight-obese subjects or with moderate-high disease activity index are increased the risk of metabolic syndrome, with statistical significance (p < 0,05). The group with at least one component of metabolic  syndrome has higher prevalence of moderate-high disease activity index than the one with no component. Conclusion: Metabolic syndrome in patients with spondyloarthritis has a high prevalence (29,6%) and the study groups with aged ≥ 35 years, overweight-obese and with moderate-high disease activity index increase the risk of it.